Littérature scientifique sur le sujet « Immunomodulation of galf »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Sommaire
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Immunomodulation of galf ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Immunomodulation of galf"
Watzl, Bernhard, Stephanie Girrbach et Monika Roller. « Inulin, oligofructose and immunomodulation ». British Journal of Nutrition 93, S1 (avril 2005) : S49—S55. http://dx.doi.org/10.1079/bjn20041357.
Texte intégralLührmann, Anja, Jürgen Thölke, Ingrid Behn, Jens Schumann, Gisa Tiegs et Sunna Hauschildt. « Immunomodulating Properties of the Antibiotic Novobiocin in Human Monocytes ». Antimicrobial Agents and Chemotherapy 42, no 8 (1 août 1998) : 1911–16. http://dx.doi.org/10.1128/aac.42.8.1911.
Texte intégralDogi, Cecilia A., et Gabriela Perdigón. « Importance of the host specificity in the selection of probiotic bacteria ». Journal of Dairy Research 73, no 3 (13 juillet 2006) : 357–66. http://dx.doi.org/10.1017/s0022029906001993.
Texte intégralWang, De, Jiahui Wang, Hui Liu, Meng Liu, Yanjing Yang et Shian Zhong. « The Main Structural Unit Elucidation and Immunomodulatory Activity In Vitro of a Selenium-Enriched Polysaccharide Produced by Pleurotus ostreatus ». Molecules 27, no 8 (18 avril 2022) : 2591. http://dx.doi.org/10.3390/molecules27082591.
Texte intégralSaavedra, J. M., et A. Tschernia. « Human studies with probiotics and prebiotics : clinical implications ». British Journal of Nutrition 87, S2 (mai 2002) : S241—S246. http://dx.doi.org/10.1079/bjn/2002543.
Texte intégralSchley, P. D., et C. J. Field. « The immune-enhancing effects of dietary fibres and prebiotics ». British Journal of Nutrition 87, S2 (mai 2002) : S221—S230. http://dx.doi.org/10.1079/bjn/2002541.
Texte intégralGonçalves, Ana Teresa, Valentina Valenzuela-Muñoz et Cristian Gallardo-Escárate. « Intestinal transcriptome modulation by functional diets in rainbow trout : A high-throughput sequencing appraisal to highlight GALT immunomodulation ». Fish & ; Shellfish Immunology 64 (mai 2017) : 325–38. http://dx.doi.org/10.1016/j.fsi.2017.03.022.
Texte intégralGubergrits, N. B., N. V. Byelyayeva, A. Ye Klochkov, G. M. Lukashevich et P. G. Fomenko. « Drug-induced liver injury : from pathogenesis to treatment ». Herald of Pancreatic Club 46, no 1 (26 mars 2020) : 72–80. http://dx.doi.org/10.33149/vkp.2020.01.10.
Texte intégralKoscielny, A., D. Engel, J. Maurer, S. Wehner, C. Kurts et J. C. Kalff. « The role of lymphoid tissue in the attenuation of the postoperative ileus ». American Journal of Physiology-Gastrointestinal and Liver Physiology 304, no 4 (15 février 2013) : G401—G412. http://dx.doi.org/10.1152/ajpgi.00161.2012.
Texte intégralZhang, Wuxia, Yihua Hu, Jiaqi He, Dongdong Guo, Jinzhong Zhao et Peng Li. « Structural Characterization and Immunomodulatory Activity of a Novel Polysaccharide From Lycopi Herba ». Frontiers in Pharmacology 12 (25 juin 2021). http://dx.doi.org/10.3389/fphar.2021.691995.
Texte intégralThèses sur le sujet "Immunomodulation of galf"
BORTESI, Luisa. « Expression of murine and viral interleukin-10 in tobacco for immunomodulation of galt for the prevention of autoimmune diseases ». Doctoral thesis, Università degli Studi di Verona, 2009. http://hdl.handle.net/11562/337378.
Texte intégralInterleukin-10 (IL-10) is a potent anti-inflammatory cytokine, with therapeutic applications in several autoimmune and inflammatory diseases. Oral administration of this cytokine, alone or in combination with disease-associated autoantigens, could confer protection form the onset of a specific autoimmune disease through the induction of oral tolerance. Transgenic plants are attractive systems for production of therapeutic proteins because of the ability to do large scale-up at low cost, and the low maintenance requirements. They are highly amenable to oral administration and could become effective delivery systems without extensive protein purification. The ability of tobacco plants to produce high levels of biologically-active viral and murine IL-10 was investigated. To reach high accumulation levels of the transgenes, plastid transformation of the IL-10 genes as well as different targeting strategies of the nuclear encoded recombinant proteins were investigated. Chloroplast transformation turned out not to be a feasible approach for the recombinant production of IL-10, as unsatisfactory accumulation levels were obtained upon expression of both transgenes. For tobacco nuclear transformation, three different subcellular targeting strategies, directing the recombinant protein into the endoplasmic reticulum (ER), cytosol and apoplast, were first assessed in transient expression experiments, and stable transgenic plants were then generated with the constructs that yielded the highest accumulation levels by targeting the recombinant proteins to the ER. The recombinant proteins were purified from transgenic leaf material and characterized in terms of their N-glycan composition, dimerization, stability and biological activity in in vitro assays. Both molecules formed stable dimers, were able to activate the IL-10 signaling pathway and to induce specific anti-inflammatory responses in mouse J774 macrophage cells. It was therefore demonstrated that tobacco plants are able to correctly process viral and murine IL- 10 into biologically active dimers, representing a suitable platform for the production for these cytokines. The accumulation levels obtained are high enough to allow delivery of an immunologically relevant dose of IL-10 in a reasonable amount of leaf material, without extensive purification. This study paves the way to performing feeding studies in mouse models of autoimmune diseases, that will allow evaluation of the immunomodulatory properties and effectiveness of the viral and murine IL-10 in inducing oral tolerance.